Global DHA and EPA Products Market Size By Type (Triglycerides, Ethyl Esters), By Application (Infant Formulae, Dietary Supplements), By Region, And Segment Forecasts, 2023 to 2032

The Global DHA and EPA Products Market was valued at USD 5.6 billion in 2023 and is projected to reach USD 9.1 billion by 2031, expanding at a CAGR of 6.4% from 2023 to 2031. The market is witnessing strong growth due to increasing health awareness, growing demand for omega-3 fatty acids, and their wide-ranging health benefits in cardiovascular, neurological, and prenatal care. DHA (Docosahexaenoic Acid) and EPA (Eicosapentaenoic Acid), primarily sourced from fish oil and algae, are gaining popularity in dietary supplements, pharmaceuticals, functional foods, and infant formulas.

Drivers:

1. Rising Health Consciousness: The global trend toward health and wellness has significantly increased consumer demand for nutritional supplements rich in omega-3 fatty acids. DHA and EPA are recognized for reducing inflammation, supporting heart health, and improving cognitive functions.

2. Aging Population and Preventive Healthcare: As the global population ages, there is a growing focus on preventive healthcare and maintaining quality of life. DHA and EPA help reduce the risk of chronic diseases, such as Alzheimer’s and arthritis, driving their adoption among older adults.

3. Regulatory Support and Awareness Campaigns: Supportive regulations for dietary supplements and increasing awareness campaigns by health organizations about omega-3 benefits are encouraging consumers to include DHA and EPA in their diets.

Restraints:

1. Sustainability and Source Limitations: Dependence on marine sources such as fish oil raises concerns regarding overfishing and ecological balance. Sustainability issues may restrict raw material availability and production scalability.

2. Price Volatility of Raw Materials: Fluctuations in the cost of raw materials, especially marine-based oils, impact the final pricing of DHA and EPA products, creating challenges for manufacturers and limiting access in price-sensitive markets.

Opportunity:

1. Plant-based and Algae-Derived Omega-3 Products: With rising veganism and demand for plant-based alternatives, the market is seeing a shift toward algae-derived DHA and EPA products. These sources offer a sustainable and vegetarian-friendly alternative to fish oil.

2. Expansion in Emerging Economies: Rapid urbanization, rising disposable income, and growing awareness of nutritional benefits in countries such as India, Brazil, and China offer lucrative growth opportunities for market players.

Market by System Type Insights:

By system type, the Fish Oil-Derived DHA and EPA segment dominated the market in 2023 due to its high bioavailability and established consumer base. However, Algae-Derived DHA and EPA products are expected to witness the fastest growth during the forecast period, attributed to their sustainability and appeal among vegetarian consumers.

Market by End-use Insights:

The Dietary Supplements segment held the largest market share in 2023, driven by increasing consumer focus on self-care and nutritional supplementation. The Infant Formula segment is also experiencing robust growth, owing to the crucial role of DHA in infant brain and eye development.

Market by Regional Insights:

North America dominated the global DHA and EPA products market in 2023, owing to a mature nutraceutical sector, high consumer awareness, and strong distribution networks. Asia-Pacific is expected to exhibit the highest CAGR through 2031, led by increasing health awareness, urbanization, and favorable regulatory frameworks in countries like China, Japan, and India.

Competitive Scenario:

Key market players include DSM Nutritional Products, BASF SE, Croda International Plc, Corbion NV, KD Pharma Group, Nordic Naturals, Epax Norway AS, GC Rieber Oils, Pharma Marine AS, and Polaris SA. These companies focus on strategic acquisitions, product launches, and investment in algae-based DHA/EPA production technologies to expand their global footprint.

Key Developments:

2023: DSM introduced a new range of algae-sourced omega-3 supplements aimed at vegan and vegetarian consumers.

2024: BASF launched a microencapsulated DHA powder for enhanced stability in functional foods.

2025: Corbion announced an expansion of its algae fermentation facility to meet growing demand for sustainable omega-3 production.

Scope of Work – Global DHA and EPA Products Market

Report Metric Details

Market Size (2023) USD 5.6 billion

Projected Market Size (2031) USD 9.1 billion

CAGR (2023–2031) 6.4%

Market Segments By Source (Fish Oil, Algae), By End-use (Dietary Supplements, Infant Formula, Pharmaceuticals, Functional Foods), By Region

Growth Drivers Rising health awareness, aging population, supportive regulations

Opportunities Plant-based alternatives, emerging market penetration

FAQs:

1) What is the current market size of the Global DHA and EPA Products Market?

The market size was valued at USD 5.6 billion in 2023.

2) What is the major growth driver of the Global DHA and EPA Products Market?

The rising health awareness and demand for omega-3-based nutritional supplements are key growth drivers.

3) Which is the largest region during the forecast period in the Global DHA and EPA Products Market?

North America holds the largest market share as of 2023.

4) Which segment accounted for the largest market share in the Global DHA and EPA Products Market?

The Dietary Supplements segment accounted for the largest share in 2023.

5) Who are the key market players in the Global DHA and EPA Products Market?

DSM, BASF SE, Croda International, Corbion NV, and Nordic Naturals are among the leading players.